Pre-Menopause, Menopause and Beyond Volume 5: Frontiers in Gynecological Endocrinology /
This volume represents an up-to-date overview on pre-Menopause and Menopause, with their respective clinical implications and therapies. The aim is to clarify possible doubts and clinical approaches to this particular period in a woman's life and how to face it, both offering solutions to actua...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
| Έκδοση: | 1st ed. 2018. |
| Σειρά: | ISGE Series,
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Part I Menopause: symptoms and neuroendocrine impact Intracrinology made menopause possible
- From menopause to aging: endocrine and neuroendocrine biological changes
- Brain impact of sex steroids withdrawall of the menopause
- Climacteric symptoms: importance and management
- Part II Fertility 2016 IMS Recommendations on women's midlife health, "POI" and menopause hormone therapy (MHT)
- Female infertility and autoimmunity
- Is IVF/ICSI/ET reasonable beyond the female age of 40 years?
- IVF: new developments in patient tailored ovarian stimulation
- Oocyte donation in peri-menopausal and menopausal women
- Part III Thyroid disorders, polycystic ovary and metabolic syndrome Thyroid disorders in climacteric women
- Thyroid function and pregnancy outcome after ART: what is the evidence?
- PCOS: implications of cardio-metabolic dysfunction
- Why Metformin is so important for prevention and treatment in climacteric women?
- Metabolic changes during menopausal trans ition
- Weight and body composition management after menopause
- Part IV Bone and cardiovascular impact Healthy bones after menopause - what has to be done?
- The effect of menopause and HRT on coronary heart disease
- How to prevent cardiovascular disorders: influence of gonadal steroids on the heart
- Part V Benign breast diseases, BRCA mutation and breast cancer Risk reducing surgery and treatment of menopausal symptoms in BRCA mutation carriers (and other high risk women)
- Benign breast disease during women's life
- Treatment of menopausal symptoms in breast cancer survivors
- Myo-inositol and Inositol Hexaphosphate (IP6) in the treatment of breast cancer
- Part VI Menopause symptoms: the therapies The true risks of hormone replacement therapy
- Menopausal hormone therapy customization
- Vulvovaginal atrophy (VVA) and Genitourinary Syndrome of Menopause (GSM): Advances in management
- Menopause symptoms: new treatment options
- Intravaginal DHEA for the treatment of vaginal atrophy closest to physiology
- Part VII Surgical challenges after menopause: problems and solutions Bladder dysfunction and urinary incontinence after the menopause: hormones, drugs or surgery?
- When is ovarectomy and when tubectomy indicated at necessary hysterectomies beyond the reproductive age?
- Pelvic floor reconstructive surgery in ageing women: tailoring the treatment to each woman's needs.
